• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人类免疫缺陷病毒1型共受体CXCR-4(融合素、LESTR)和CKR-5在CD34+造血祖细胞中的表达。

Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells.

作者信息

Deichmann M, Kronenwett R, Haas R

机构信息

Klinische Kooperationseinheit Molekulare Hamatologie/Onkologie, Deutsches Krebsforschungszentrum, Heidelberg, Germany.

出版信息

Blood. 1997 May 15;89(10):3522-8.

PMID:9160656
Abstract

CD34+ hematopoietic progenitor cells were assessed for mRNA expression of the human immunodeficiency virus type-1 (HIV-1) coreceptors CXCR-4, also termed fusin or LESTR, and CKR-5, also called CC-CKR-5 or CCR-5. The CD34+ cells were obtained from leukapheresis products of 17 patients after granulocyte colony-stimulating factor-supported cytotoxic chemotherapy. Using a two-step enrichment procedure including immunomagnetic bead separation and fluorescence-activated cell sorting, the CD34+ cells had a median purity of 99.8%. Assessing 9 CD34+ cell samples by polymerase chain reaction after reverse transcription (RT-PCR), CXCR-4 mRNA was found in all samples, whereas CKR-5 mRNA was only present in 3 samples, even though a nested PCR was used. Eight additional CD34+ cell samples were sorted according to CD4 expression. Based on a three-color immunofluorescence analysis, the mean relative fluorescence intensity of HLA-DR was smaller on CD34+/CD4+ cells in comparison with CD34+/ CD4- cells. CXCR-4 mRNA was found in 5 of 8 CD34+/CD4+ samples and in 7 of 8 CD34+/CD4- samples, whereas CKR-5 mRNA was detected in 2 CD34+/CD4+ samples and in 1 CD34+/CD4- cell sample. Looking at the total number of CD34+ cell samples examined, the proportion of specimens containing CXCR-4 mRNA was 84% in comparison with 24% of specimens positive for CKR-5 mRNA. These data suggest that CD34+/CD4+ hematopoietic progenitor cells, including true stem cell candidates, could be susceptible to HIV-1 infection. Considering the relatively low incidence of CD34+ cell samples containing CKR-5 mRNA, CD34+/CD4+ cells appear to be particularly prone for HIV-1 infection via the CXCR-4 coreceptor. Because this chemokine receptor allows T-cell-tropic HIV-1 strains to infect cells, CD34+ cells expressing CD4 and CXCR-4 might be infected by HIV-1 during later stages of the disease, following a viral phenotype switch from macrophage- to T-cell-tropic HIV-1 strains.

摘要

对CD34 +造血祖细胞进行了人类免疫缺陷病毒1型(HIV - 1)共受体CXCR - 4(也称为融合素或LESTR)和CKR - 5(也称为CC - CKR - 5或CCR - 5)的mRNA表达评估。CD34 +细胞取自17例患者在粒细胞集落刺激因子支持的细胞毒性化疗后的白细胞分离产物。采用包括免疫磁珠分离和荧光激活细胞分选的两步富集程序,CD34 +细胞的中位纯度为99.8%。通过逆转录聚合酶链反应(RT - PCR)对9个CD34 +细胞样本进行评估,发现所有样本中均有CXCR - 4 mRNA,而CKR - 5 mRNA仅在3个样本中存在,即便使用了巢式PCR。另外8个CD34 +细胞样本根据CD4表达进行分选。基于三色免疫荧光分析,与CD34 + / CD4 -细胞相比,CD34 + / CD4 +细胞上HLA - DR的平均相对荧光强度较小。在8个CD34 + / CD4 +样本中有5个以及在8个CD34 + / CD4 -样本中有7个发现了CXCR - 4 mRNA,而在2个CD34 + / CD4 +样本和1个CD34 + / CD4 -细胞样本中检测到了CKR - 5 mRNA。从所检测的CD34 +细胞样本总数来看,含有CXCR - 4 mRNA的标本比例为84%,而含有CKR - 5 mRNA的阳性标本比例为24%。这些数据表明,包括真正干细胞候选者在内的CD34 + / CD4 +造血祖细胞可能易受HIV - 1感染。考虑到含有CKR - 5 mRNA的CD34 +细胞样本发生率相对较低,CD34 + / CD4 +细胞似乎特别容易通过CXCR - 4共受体感染HIV - 1。由于这种趋化因子受体允许嗜T细胞的HIV - 1毒株感染细胞,表达CD4和CXCR - 4的CD34 +细胞可能在疾病后期被HIV - 1感染,这发生在病毒表型从巨噬细胞嗜性HIV - 1毒株转变为嗜T细胞的HIV - 1毒株之后。

相似文献

1
Expression of the human immunodeficiency virus type-1 coreceptors CXCR-4 (fusin, LESTR) and CKR-5 in CD34+ hematopoietic progenitor cells.人类免疫缺陷病毒1型共受体CXCR-4(融合素、LESTR)和CKR-5在CD34+造血祖细胞中的表达。
Blood. 1997 May 15;89(10):3522-8.
2
The human immunodeficiency virus (HIV)-type 1 coreceptor CXCR-4 (fusin) is preferentially expressed on the more immature CD34+ hematopoietic stem cells.人类免疫缺陷病毒1型(HIV-1)共受体CXCR-4(融合素)在更不成熟的CD34+造血干细胞上优先表达。
Ann Hematol. 1998 Nov;77(5):193-7. doi: 10.1007/s002770050442.
3
CD34+ cells and their derivatives contain mRNA for CD4 and human immunodeficiency virus (HIV) co-receptors and are susceptible to infection with M- and T-tropic HIV.CD34+细胞及其衍生物含有CD4和人类免疫缺陷病毒(HIV)共受体的信使核糖核酸(mRNA),并且易受M嗜性和T嗜性HIV的感染。
J Gen Virol. 1998 Jan;79 ( Pt 1):71-5. doi: 10.1099/0022-1317-79-1-71.
4
Coreceptor/chemokine receptor expression on human hematopoietic cells: biological implications for human immunodeficiency virus-type 1 infection.人类造血细胞上共受体/趋化因子受体的表达:对1型人类免疫缺陷病毒感染的生物学意义
Blood. 1999 Feb 15;93(4):1145-56.
5
Lineage-specific expression of human immunodeficiency virus (HIV) receptor/coreceptors in differentiating hematopoietic precursors: correlation with susceptibility to T- and M-tropic HIV and chemokine-mediated HIV resistance.人类免疫缺陷病毒(HIV)受体/共受体在分化的造血前体细胞中的谱系特异性表达:与对T嗜性和M嗜性HIV的易感性及趋化因子介导的HIV抗性的相关性
Blood. 1999 Sep 1;94(5):1590-600.
6
CD4, CXCR-4, and CCR-5 dependencies for infections by primary patient and laboratory-adapted isolates of human immunodeficiency virus type 1.原发性患者和实验室适应性1型人类免疫缺陷病毒分离株感染对CD4、CXCR-4和CCR-5的依赖性
J Virol. 1997 Feb;71(2):873-82. doi: 10.1128/JVI.71.2.873-882.1997.
7
A dual-tropic primary HIV-1 isolate that uses fusin and the beta-chemokine receptors CKR-5, CKR-3, and CKR-2b as fusion cofactors.一种双嗜性原发性HIV-1分离株,其利用融合素以及β趋化因子受体CKR-5、CKR-3和CKR-2b作为融合辅助因子。
Cell. 1996 Jun 28;85(7):1149-58. doi: 10.1016/s0092-8674(00)81314-8.
8
Modulation of CD4, CXCR-4, and CCR-5 makes human hematopoietic progenitor cell lines infected with human herpesvirus-6 susceptible to human immunodeficiency virus type 1.CD4、CXCR-4和CCR-5的调节使感染人类疱疹病毒6型的人类造血祖细胞系易受1型人类免疫缺陷病毒感染。
J Hematother Stem Cell Res. 2000 Feb;9(1):39-45. doi: 10.1089/152581600319603.
9
The chemokine receptor CXCR-4 is expressed on CD34+ hematopoietic progenitors and leukemic cells and mediates transendothelial migration induced by stromal cell-derived factor-1.趋化因子受体CXCR-4在CD34+造血祖细胞和白血病细胞上表达,并介导由基质细胞衍生因子-1诱导的跨内皮迁移。
Blood. 1998 Jun 15;91(12):4523-30.
10
Primary, syncytium-inducing human immunodeficiency virus type 1 isolates are dual-tropic and most can use either Lestr or CCR5 as coreceptors for virus entry.原发性、诱导合胞体的1型人类免疫缺陷病毒分离株具有双嗜性,大多数可使用Lestr或CCR5作为病毒进入的共受体。
J Virol. 1996 Dec;70(12):8355-60. doi: 10.1128/JVI.70.12.8355-8360.1996.

引用本文的文献

1
The Chemokine Receptor CXCR4 Mediates Recruitment of CD11c+ Conventional Dendritic Cells Into the Inflamed Murine Cornea.趋化因子受体 CXCR4 介导 CD11c+ 常规树突状细胞募集到炎症性的小鼠角膜中。
Invest Ophthalmol Vis Sci. 2018 Nov 1;59(13):5671-5681. doi: 10.1167/iovs.18-25084.
2
A tale of two macrophages: to Shb or not to Shb.两种巨噬细胞的故事:与Shb有关与否。
Acta Physiol (Oxf). 2015 Jun;214(2):152-3. doi: 10.1111/apha.12504. Epub 2015 Apr 20.
3
Neutropenia during HIV infection: adverse consequences and remedies.HIV感染期间的中性粒细胞减少症:不良后果与补救措施
Int Rev Immunol. 2014 Nov-Dec;33(6):511-36. doi: 10.3109/08830185.2014.893301. Epub 2014 Mar 21.
4
Effects of human immunodeficiency virus on the erythrocyte and megakaryocyte lineages.人类免疫缺陷病毒对红细胞系和巨核细胞系的影响。
World J Virol. 2013 May 12;2(2):91-101. doi: 10.5501/wjv.v2.i2.91.
5
HIV-1 infection of hematopoietic progenitor cells in vivo in humanized mice.在人源化小鼠体内的造血祖细胞中 HIV-1 的感染。
Blood. 2013 Sep 26;122(13):2195-204. doi: 10.1182/blood-2013-04-496950. Epub 2013 Jul 25.
6
Human immunodeficiency virus (HIV) latency: the major hurdle in HIV eradication.人类免疫缺陷病毒(HIV)潜伏期:HIV 根除的主要障碍。
Mol Med. 2012 Sep 25;18(1):1096-108. doi: 10.2119/molmed.2012.00194.
7
Transcriptional regulation of the chemokine co-receptor CCR5 by the cAMP/PKA/CREB pathway.CCR5 趋化因子共受体的转录调控由 cAMP/PKA/CREB 通路介导。
Biomed Pharmacother. 2011 Jul;65(4):293-7. doi: 10.1016/j.biopha.2011.03.009. Epub 2011 May 30.
8
Quality assessment of cellular therapies: the emerging role of molecular assays.细胞疗法的质量评估:分子检测的新兴作用
Korean J Hematol. 2010 Mar;45(1):14-22. doi: 10.5045/kjh.2010.45.1.14. Epub 2010 Mar 31.
9
Molecular mechanisms of HIV-1 persistence in the monocyte-macrophage lineage.HIV-1 在单核细胞-巨噬细胞谱系中持续存在的分子机制。
Retrovirology. 2010 Apr 9;7:32. doi: 10.1186/1742-4690-7-32.
10
Global transcriptional analysis for biomarker discovery and validation in cellular therapies.用于细胞疗法中生物标志物发现与验证的全转录组分析。
Mol Diagn Ther. 2009;13(3):181-93. doi: 10.2165/01250444-200913030-00003.